- Report
- May 2022
- 66 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Drug Pipelines
- September 2018
- 150 Pages
Global
From €3378EUR$3,500USD£2,898GBP
- Book
- June 2020
- 198 Pages
- Report
- November 2021
- 747 Pages
Global
From €3861EUR$4,000USD£3,312GBP
- Report
- April 2023
- 147 Pages
Global
From €5790EUR$5,999USD£4,967GBP
- Book
- April 2023
- 2000 Pages
- Book
- June 2022
- 496 Pages
- Book
- April 2020
- 320 Pages
- Book
- February 2018
- 448 Pages
- Book
- February 2018
- 784 Pages
- Book
- March 2017
- 2008 Pages
- Book
- April 2022
- 656 Pages
Global
Tumor suppressor drugs are a type of oncology drug used to treat cancer. They work by inhibiting the growth of cancer cells, either by blocking the growth of new cells or by killing existing cells. Tumor suppressors are typically used in combination with other treatments, such as chemotherapy or radiation therapy, to maximize the effectiveness of the treatment. They are also used to reduce the risk of recurrence of cancer after treatment.
Tumor suppressors are typically administered orally or intravenously, depending on the type of cancer being treated. Common side effects of tumor suppressors include nausea, vomiting, fatigue, and hair loss.
The tumor suppressor market is a rapidly growing segment of the oncology drug market. As the number of cancer cases continues to rise, the demand for effective treatments is increasing. This has led to an increase in research and development of new tumor suppressor drugs, as well as the development of new delivery methods.
Some companies in the tumor suppressor market include Novartis, Merck, Pfizer, and AstraZeneca. Show Less Read more